Skip to content
NBlaz – Lifestyle
Author:
Braeburn
Braeburn Announces Publication of Postmarketing Safety Analysis Evaluating BRIXADI® in The Journal of Substance Use & Addiction Treatment
September 15, 2026
Braeburn to Present Research at CPDD 2026 Annual Meeting, Including Data on Withdrawal Suppression and Real-World Treatment Retention in Patients With Opioid Use Disorder
June 12, 2026
Braeburn Presents New Data at 2026 ASCP Annual Meeting Demonstrating Opioid Withdrawal Suppression at Low Buprenorphine Plasma Concentrations
May 28, 2026